Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | ENTPD3 | O75355 | 1/20 | 1.00 |
| ▸ | ENPP1 | P22413 | 1/20 | 1.00 |
| ▸ | ENTPD1 | P49961 | 1/20 | 1.00 |
| ▸ | RGS12 | O14924 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.72 |
| ▸ | GK | P32189 | 1/20 | 0.64 |
| ▸ | CD79B | P40259 | 1/20 | 0.64 |
| ▸ | P2RY1 | P47900 | 6/20 | 0.63 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.63 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.63 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31309982 | 1.00 | NT5E (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL13105971 | 1.00 | NT5E (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL21122194 | 1.00 | NT5E (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL12732611 | 1.00 | NT5E (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL13096782 | 1.00 | NT5E (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL12648394 | 0.85 | KDM4E (0.73) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL31191554 | 0.84 | RGS12 (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL29502825 | 0.84 | RGS12 (1.00) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL29430335 | 0.83 | RGS12 (0.90) | NT5EKDM4EMEN1CYP1A2CYP2D6 | |
| SCHEMBL21362874 | 0.82 | NT5E (0.69) | NT5EKDM4EMEN1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270767-A1 | INHIBITORS OF ENPP1 AND METHODS OF USING SAME | UNITED STATES GOVERNMENT | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270767-A1 | INHIBITORS OF ENPP1 AND METHODS OF USING SAME | ENPP1, ENPP3, ENPP2 | NT5E 133/4885KDM4E 2476/4885MEN1 1239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.